Mycobacterium haemophilum is an environmental organism that rarely causes infections in humans. We report a patient with acquired immunodeficiency syndrome who had central nervous system infection due to M. haemophilum. The diagnosis required brain tissue procurement and molecular identification method while the treatment outcome was unfavourable.
LindeboomJABruijnesteijn van CoppenraetLEvan SoolingenD. Clinical manifestations, diagnosis, and treatment of Mycobacterium haemophilum infections. Clin Microbiol Rev2011; 24: 701–717.
2.
Garcia-AgudoLJesusIRodriguez-IglesiasM. Evaluation of INNO-LiPA mycobacteria v2 assay for identification of rapidly growing mycobacteria. Braz J Microbiol2011; 42: 1220–1226.
3.
StrausWLOstroffSMJerniganDB. Clinical and epidemiologic characteristics of Mycobacterium haemophilum an emerging pathogen in immunocompromised patients. Ann Intern Med1994; 120: 118–125.
4.
SturenburgEEHorstkotteMAAberleJ. Disseminated Mycobacterium haemophilum infection as initial manifestation of AIDS. Tuberculosis (Edinb)2004; 84: 341–345.
5.
ChanKEPathmanathanT. Meningitis due to atypical Mycobacteria. Med J Malaya1961; 15: 113–116.
6.
JacobCNHeneinSSHeurichAE. Nontuberculous mycobacterial infection of the central nervous system in patients with AIDS. South Med J1993; 86: 638–640.
7.
KleinNCDamskerBHirschmanSZ. Mycobacterial meningitis. Retrospective analysis from 1970 to 1983. Am J Med1985; 79: 29–34.
PhowthongkumPPuengchitprapaiAUdomsantisookN. Spindle cell pseudotumor of the brain associated with Mycobacterium haemophilum and Mycobacterium simiae mixed infection in a patient with AIDS: the first case report. Int J Infect Dis2008; 12: 421–424.
10.
TortoliEMariottiniAMazzarelliG. Evaluation of INNO-LiPA MYCOBACTERIA v2: improved reverse hybridization multiple DNA probe assay for mycobacterial identification. J Clin Microbiol2003; 41: 4418–4420.
11.
LeeMRChengALeeYC. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates. J Antimicrob Chemother2012; 67: 222–225.
12.
NauRSorgelFEiffertH. Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev2010; 23: 858–883.
